Cezmi Akdis
#67,178
Most Influential Person Now
Researcher
Cezmi Akdis's AcademicInfluence.com Rankings
Cezmi Akdisbiology Degrees
Biology
#2822
World Rank
#4412
Historical Rank
Immunology
#107
World Rank
#113
Historical Rank
Neuroscience
#372
World Rank
#389
Historical Rank
Download Badge
Biology
Cezmi Akdis's Degrees
- PhD Immunology University of Zurich
Why Is Cezmi Akdis Influential?
(Suggest an Edit or Addition)According to Wikipedia, Cezmi Akdis is a medical researcher in the field of immunology. He is director of the Swiss Institute of Allergy and Asthma Research in Davos, Switzerland and the editor in chief of the journal Allergy.
Cezmi Akdis's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China (2020) (3191)
- Immune Responses in Healthy and Allergic Individuals Are Characterized by a Fine Balance between Allergen-specific T Regulatory 1 and T Helper 2 Cells (2004) (1088)
- Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. (2011) (1043)
- EAACI Food Allergy and Anaphylaxis Guidelines: diagnosis and management of food allergy (2014) (1026)
- Role of interleukin 10 in specific immunotherapy. (1998) (992)
- IL‐10 and TGF‐β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy (2003) (920)
- Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology (2014) (814)
- Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19 (2020) (765)
- Immunological mechanisms of allergen-specific immunotherapy (2006) (759)
- Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases. (2011) (730)
- Mechanisms of immune suppression by interleukin‐10 and transforming growth factor‐β: the role of T regulatory cells (2006) (637)
- Mechanisms of allergen-specific immunotherapy (2012) (589)
- Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors (2001) (564)
- IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses. (2013) (524)
- Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: Receptors, functions, and roles in diseases. (2016) (518)
- Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. (2004) (503)
- Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. (2006) (469)
- Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. (1998) (462)
- Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. (2013) (462)
- In vivo switch to IL-10–secreting T regulatory cells in high dose allergen exposure (2008) (460)
- IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. (2014) (459)
- Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens. (2014) (450)
- Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report. (2013) (446)
- T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. (2000) (444)
- Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report (2006) (434)
- Cellular and molecular immunologic mechanisms in patients with atopic dermatitis. (2016) (434)
- Risk factors for severe and critically ill COVID‐19 patients: A review (2020) (431)
- International consensus on allergy immunotherapy. (2015) (427)
- EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis (2018) (407)
- Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals (2019) (390)
- International consensus on (ICON) pediatric asthma (2012) (382)
- Distribution of ACE2, CD147, CD26, and other SARS‐CoV‐2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID‐19 risk factors (2020) (376)
- Mechanisms of interleukin‐10‐mediated immune suppression (2001) (367)
- Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-γ and IL-4. (2012) (362)
- Role of Treg in immune regulation of allergic diseases (2010) (359)
- International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) (351)
- T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic diseases. (2005) (346)
- Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. (2009) (344)
- EAACI Guidelines on allergen immunotherapy: IgE‐mediated food allergy (2018) (332)
- T-cell regulation in chronic paranasal sinus disease. (2008) (323)
- Untangling asthma phenotypes and endotypes (2012) (316)
- Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and toll‐like receptors (2008) (313)
- Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. (1996) (311)
- The biodiversity hypothesis and allergic disease: world allergy organization position statement (2013) (311)
- Immunological mechanisms of allergen‐specific immunotherapy (2011) (307)
- EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy (2018) (293)
- Mechanisms of allergen-specific immunotherapy. (2007) (292)
- Allergen immunotherapy for IgE‐mediated food allergy: a systematic review and meta‐analysis (2017) (291)
- Eleven faces of coronavirus disease 2019 (2020) (286)
- TH17 cells in the big picture of immunology. (2007) (275)
- GATA3-Driven Th2 Responses Inhibit TGF-β1–Induced FOXP3 Expression and the Formation of Regulatory T Cells (2007) (273)
- Histamine, histamine receptors and their role in immune pathology (2009) (272)
- Epidemiology, clinical features, and immunology of the “intrinsic” (non‐IgE‐mediated) type of atopic dermatitis (constitutional dermatitis) (2001) (270)
- Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens (2015) (262)
- Risk factors for severe and critically ill COVID-19 patients: a review (2020) (261)
- Absence of T-regulatory cell expression and function in atopic dermatitis skin. (2006) (261)
- Therapies for allergic inflammation: refining strategies to induce tolerance (2012) (260)
- Precision medicine in patients with allergic diseases: Airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. (2016) (257)
- IL‐10‐induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: two key steps in specific immunotherapy (1999) (256)
- Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions? (2021) (246)
- Bifidobacterium infantis 35624 administration induces Foxp3 T regulatory cells in human peripheral blood: potential role for myeloid and plasmacytoid dendritic cells (2011) (243)
- Histamine receptors are hot in immunopharmacology. (2006) (238)
- IL‐10 directly acts on T cells by specifically altering the CD28 co‐stimulation pathway (2000) (238)
- Regulation of the immune response and inflammation by histamine and histamine receptors. (2011) (237)
- Regulatory NK Cells Suppress Antigen-Specific T Cell Responses1 (2008) (237)
- Immune regulation by histamine. (2002) (236)
- Regulatory T cells and immune regulation of allergic diseases: roles of IL-10 and TGF-β (2014) (236)
- Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections. (2012) (235)
- High levels of butyrate and propionate in early life are associated with protection against atopy (2018) (232)
- Allergen immunotherapy for allergic asthma: A systematic review and meta‐analysis (2017) (226)
- Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. (2012) (224)
- Histamine in the immune regulation of allergic inflammation. (2003) (224)
- An Interleukin-33-Mast Cell-Interleukin-2 Axis Suppresses Papain-Induced Allergic Inflammation by Promoting Regulatory T Cell Numbers. (2015) (222)
- Immunologic mechanisms in asthma. (2019) (217)
- Skin homing (cutaneous lymphocyte-associated antigen-positive) CD8+ T cells respond to superantigen and contribute to eosinophilia and IgE production in atopic dermatitis. (1999) (216)
- Impaired barrier function in patients with house dust mite-induced allergic rhinitis is accompanied by decreased occludin and zonula occludens-1 expression. (2016) (214)
- Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells (2009) (206)
- Clinical phenotypes and endophenotypes of atopic dermatitis: Where are we, and where should we go? (2017) (206)
- Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells (2017) (206)
- T cells and eosinophils cooperate in the induction of bronchial epithelial cell apoptosis in asthma. (2002) (205)
- Projections of the effects of climate change on allergic asthma: the contribution of aerobiology (2010) (202)
- Skin-homing, CLA+ memory T cells are activated in atopic dermatitis and regulate IgE by an IL-13-dominated cytokine pattern: IgG4 counter-regulation by CLA- memory T cells. (1997) (199)
- International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics. (2016) (197)
- Therapeutic manipulation of immune tolerance in allergic disease (2009) (196)
- Type 2 immunity in the skin and lungs (2020) (195)
- T cells and T cell-derived cytokines as pathogenic factors in the nonallergic form of atopic dermatitis. (1999) (193)
- Mechanisms of food allergy. (2018) (191)
- T helper (Th) 2 predominance in atopic diseases is due to preferential apoptosis of circulating memory/effector Th1 cells (2003) (188)
- MicroRNAs: Essential players in the regulation of inflammation. (2013) (185)
- Uncontrolled allergic rhinitis and chronic rhinosinusitis: where do we stand today? (2013) (183)
- Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper (2008) (178)
- Allergy and hypersensitivity: mechanisms of allergic disease. (2006) (178)
- MACVIA‐ARIA Sentinel NetworK for allergic rhinitis (MASK‐rhinitis): the new generation guideline implementation (2015) (178)
- A molecular basis for T cell suppression by IL‐10: CD28‐associated IL‐10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3‐kinase binding (2000) (175)
- TH17 and TH22 cells: a confusion of antimicrobial response with tissue inflammation versus protection. (2012) (174)
- Non‐allergic rhinitis: Position paper of the European Academy of Allergy and Clinical Immunology (2017) (168)
- MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine (2011) (166)
- Phenotypes and Emerging Endotypes of Chronic Rhinosinusitis. (2016) (164)
- Immune regulation in atopic dermatitis. (2000) (163)
- Type 2 innate lymphoid cells disrupt bronchial epithelial barrier integrity by targeting tight junctions through IL‐13 in asthmatic patients (2018) (160)
- Mechanisms of immune tolerance to allergens: role of IL-10 and Tregs. (2014) (156)
- T regulatory cells and their counterparts: masters of immune regulation (2009) (154)
- Research needs in allergy: an EAACI position paper, in collaboration with EFA (2012) (151)
- Endotypes of allergic diseases and asthma: An important step in building blocks for the future of precision medicine. (2016) (151)
- EAACI Guidelines on Allergen Immunotherapy: House dust mite‐driven allergic asthma (2019) (150)
- Induction and maintenance of allergen-specific FOXP3+ Treg cells in human tonsils as potential first-line organs of oral tolerance. (2012) (147)
- Mechanisms of the Development of Allergy (MeDALL): Introducing novel concepts in allergy phenotypes (2017) (147)
- Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis (2017) (146)
- Categorization of allergic disorders in the new World Health Organization International Classification of Diseases (2014) (146)
- Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma (2020) (146)
- Regulation of T cells and cytokines by the interleukin‐10 (IL‐10)‐family cytokines IL‐19, IL‐20, IL‐22, IL‐24 andIL‐26 (2006) (144)
- MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes. (2014) (144)
- A Th17- and Th2-skewed cytokine profile in cystic fibrosis lungs represents a potential risk factor for Pseudomonas aeruginosa infection. (2013) (143)
- IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis. (2010) (142)
- Precision medicine and phenotypes, endotypes, genotypes, regiotypes, and theratypes of allergic diseases (2019) (141)
- Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis. (2001) (141)
- Mechanisms of allergen specific immunotherapy – T‐cell tolerance and more (2006) (140)
- Induction of interleukin‐10 and suppressor of cytokine signalling‐3 gene expression following peptide immunotherapy (2006) (139)
- Clinical characteristics of 182 pediatric COVID‐19 patients with different severities and allergic status (2020) (137)
- The Influence of Dietary Fatty Acids on Immune Responses (2019) (136)
- T-cell Subset Regulation in Atopy (2011) (134)
- Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen, Bet v 1 (2001) (133)
- Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID‐19 patients (2020) (131)
- Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA‐ARIA‐EPOS‐AIRWAYS ICP statement (2017) (129)
- Impact of Sublingual Immunotherapy on Specific Antibody Levels in Asthmatic Children Allergic to House Dust Mites (2005) (129)
- Regulation of bronchial epithelial barrier integrity by type 2 cytokines and histone deacetylases in asthmatic patients (2017) (129)
- IL-10-overexpressing B cells regulate innate and adaptive immune responses. (2015) (128)
- EAACI Food Allergy and Anaphylaxis Guidelines: managing patients with food allergy in the community (2014) (127)
- EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy (2012) (125)
- ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle (2016) (124)
- Intranasal corticosteroids in allergic rhinitis in COVID‐19 infected patients: An ARIA‐EAACI statement (2020) (124)
- Mechanisms of peripheral tolerance to allergens (2013) (124)
- Immunology of COVID‐19: Mechanisms, clinical outcome, diagnostics, and perspectives—A report of the European Academy of Allergy and Clinical Immunology (EAACI) (2020) (123)
- Mechanisms of IFN-γ-induced apoptosis of human skin keratinocytes in patients with atopic dermatitis. (2012) (122)
- EAACI position statement on asthma exacerbations and severe asthma (2013) (121)
- Histamine in Allergic Inflammation and Immune Modulation (2005) (121)
- Apoptosis and Loss of Adhesion of Bronchial Epithelial Cells in Asthma (2005) (121)
- Immunological mechanisms of sublingual immunotherapy (2006) (119)
- Early suppression of basophil activation during allergen-specific immunotherapy by histamine receptor 2. (2012) (118)
- Differentiation and functional analysis of human T(H)17 cells. (2009) (113)
- Increased activation-induced cell death of high IFN-gamma-producing T(H)1 cells as a mechanism of T(H)2 predominance in atopic diseases. (2008) (113)
- A wide diversity of bacteria from the human gut produces and degrades biogenic amines (2017) (111)
- TNF-like weak inducer of apoptosis (TWEAK) and TNF-α cooperate in the induction of keratinocyte apoptosis. (2011) (111)
- IL-10 inhibits CD28 and ICOS costimulations of T cells via src homology 2 domain-containing protein tyrosine phosphatase 1. (2007) (110)
- Advances in allergen immunotherapy: Aiming for complete tolerance to allergens (2015) (110)
- Treatment for food allergy (2018) (109)
- A Second Step of Chemotaxis After Transendothelial Migration: Keratinocytes Undergoing Apoptosis Release IFN-γ-Inducible Protein 10, Monokine Induced by IFN-γ, and IFN-γ-Inducible α-Chemoattractant for T Cell Chemotaxis Toward Epidermis in Atopic Dermatitis1 (2003) (109)
- The Surface-Associated Exopolysaccharide of Bifidobacterium longum 35624 Plays an Essential Role in Dampening Host Proinflammatory Responses and Repressing Local TH17 Responses (2016) (109)
- The differential fate of cadherins during T-cell-induced keratinocyte apoptosis leads to spongiosis in eczematous dermatitis. (2001) (108)
- Histamine and T helper cytokine–driven epithelial barrier dysfunction in allergic rhinitis (2017) (108)
- GA2LEN (Global Allergy and Asthma European Network) addresses the allergy and asthma ‘epidemic’ (2009) (108)
- Microbiome and asthma (2018) (108)
- Important research questions in allergy and related diseases: 3‐chronic rhinosinusitis and nasal polyposis – a GA2LEN study (2009) (107)
- Inhibition of T helper 2‐type responses, IgE production and eosinophilia by synthetic lipopeptides (2003) (107)
- Differential regulation of human T cell cytokine patterns and IgE and IgG4 responses by conformational antigen variants (1998) (107)
- Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants. (2015) (107)
- Obesity and disease severity magnify disturbed microbiome-immune interactions in asthma patients (2019) (104)
- Allergic reactions to the first COVID‐19 vaccine: A potential role of polyethylene glycol? (2020) (103)
- Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid. (2019) (103)
- Multi-morbidities of allergic rhinitis in adults: European Academy of Allergy and Clinical Immunology Task Force Report (2017) (102)
- Perspectives in allergen immunotherapy: 2019 and beyond (2019) (100)
- EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders (2015) (100)
- Portrait of an immunoregulatory bifidobacterium (2012) (100)
- Histamine receptor 2 modifies dendritic cell responses to microbial ligands. (2013) (99)
- T Regulatory Cells in Allergy and Health: A Question of Allergen Specificity and Balance (2004) (97)
- IL‐33 links tissue cells, dendritic cells and Th2 cell development in a mouse model of asthma (2011) (97)
- Mechanisms of immunotherapy to wasp and bee venom (2011) (97)
- Is diet partly responsible for differences in COVID-19 death rates between and within countries? (2020) (96)
- Is diet partly responsible for differences in COVID-19 death rates between and within countries? (2020) (96)
- Histamine-secreting microbes are increased in the gut of adult asthma patients. (2016) (95)
- Tight junction, mucin, and inflammasome‐related molecules are differentially expressed in eosinophilic, mixed, and neutrophilic experimental asthma in mice (2018) (95)
- EAACI Biologicals Guidelines—Recommendations for severe asthma (2020) (94)
- Are allergic multimorbidities and IgE polysensitization associated with the persistence or re‐occurrence of foetal type 2 signalling? The MeDALL hypothesis (2015) (93)
- Allergen immunotherapy for insect venom allergy: a systematic review and meta‐analysis (2017) (93)
- Food allergy: Update on prevention and tolerance. (2018) (93)
- Unique Phenotype of Human Tonsillar and In Vitro-Induced FOXP3+CD8+ T Cells1 (2009) (92)
- Human NK1 and NK2 subsets determined by purification of IFN‐γ‐secreting and IFN‐γ‐nonsecreting NK cells (2002) (92)
- Environmental factors in epithelial barrier dysfunction. (2020) (91)
- Immunological differences between intrinsic and extrinsic types of atopic dermatitis (2003) (91)
- Assessment of Allergic and Anaphylactic Reactions to mRNA COVID-19 Vaccines With Confirmatory Testing in a US Regional Health System (2021) (91)
- Handling of allergen immunotherapy in the COVID‐19 pandemic: An ARIA‐EAACI statement (2020) (88)
- Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma (2020) (88)
- The role of histamine in regulation of immune responses. (2006) (88)
- Advances and highlights in allergen immunotherapy: On the way to sustained clinical and immunologic tolerance (2017) (87)
- A major allergen gene-fusion protein for potential usage in allergen-specific immunotherapy. (2005) (87)
- Cytokine and Antibody Responses in Birch-Pollen-Allergic Patients Treated with Genetically Modified Derivatives of the Major Birch Pollen Allergen Bet v 1 (2005) (87)
- Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology (2019) (87)
- Identification of a B-cell epitope of hyaluronidase, a major bee venom allergen, from its crystal structure in complex with a specific Fab. (2007) (86)
- A compendium answering 150 questions on COVID‐19 and SARS‐CoV‐2 (2020) (84)
- EAACI Allergen Immunotherapy User's Guide (2020) (83)
- Triggering of specific Toll-like receptors and proinflammatory cytokines breaks allergen-specific T-cell tolerance in human tonsils and peripheral blood. (2013) (83)
- Understanding the complexity of IgE-related phenotypes from childhood to young adulthood: a Mechanisms of the Development of Allergy (MeDALL) seminar. (2012) (82)
- Regulation of the foxp3 Gene by the Th1 Cytokines: The Role of IL-27-Induced STAT11 (2009) (81)
- Apoptosis in tissue inflammation and allergic disease. (2004) (80)
- T regulatory cells in allergy. (2006) (80)
- Paving the way of systems biology and precision medicine in allergic diseases: the MeDALL success story (2016) (80)
- Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma (2019) (80)
- Allergenic components of the mRNA‐1273 vaccine for COVID‐19: Possible involvement of polyethylene glycol and IgG‐mediated complement activation (2021) (79)
- Distinct characteristics of COVID‐19 patients with initial rRT‐PCR‐positive and rRT‐PCR‐negative results for SARS‐CoV‐2 (2020) (79)
- EAACI position paper on diet diversity in pregnancy, infancy and childhood: Novel concepts and implications for studies in allergy and asthma (2020) (78)
- Immunomodulation by Bifidobacterium infantis 35624 in the Murine Lamina Propria Requires Retinoic Acid-Dependent and Independent Mechanisms (2013) (77)
- Challenges in the implementation of EAACI guidelines on allergen immunotherapy: A global perspective on the regulation of allergen products (2018) (77)
- Clinical and immunologic effects of H1 antihistamine preventive medication during honeybee venom immunotherapy. (2008) (76)
- Vascular Endothelial Growth Factor as a Key Inducer of Angiogenesis in the Asthmatic Airways (2013) (75)
- T-cell response to allergens. (2010) (75)
- Mechanism of IL-10-Induced T Cell Inactivation in Allergic Inflammation and Normal Response to Allergens (2001) (75)
- Prevention of allergy by a recombinant multi‐allergen vaccine with reduced IgE binding and preserved T cell epitopes (2005) (75)
- Inhibition of angiogenesis by IL-32: possible role in asthma. (2012) (74)
- Advances and recent developments in asthma in 2020 (2020) (73)
- COVID‐19 pandemic: Practical considerations on the organization of an allergy clinic—An EAACI/ARIA Position Paper (2020) (73)
- Considerations on biologicals for patients with allergic disease in times of the COVID‐19 pandemic: An EAACI statement (2020) (73)
- The Complex Type 2 Endotype in Allergy and Asthma: From Laboratory to Bedside (2015) (73)
- T Cell Epitope-Containing Hypoallergenic Recombinant Fragments of the Major Birch Pollen Allergen, Bet v 1, Induce Blocking Antibodies1 (2000) (72)
- Immune regulation by histamine and histamine-secreting bacteria. (2017) (72)
- Regulation of Specific Immune Responses by Chemical and Structural Modifications of Allergens (2000) (72)
- Genome Analysis and Characterisation of the Exopolysaccharide Produced by Bifidobacterium longum subsp. longum 35624™ (2016) (71)
- EAACI Food Allergy and Anaphylaxis Guidelines. Protecting consumers with food allergies: understanding food consumption, meeting regulations and identifying unmet needs (2014) (71)
- MicroRNAs in Allergy and Asthma (2014) (71)
- EAACI position paper: Influence of dietary fatty acids on asthma, food allergy, and atopic dermatitis (2019) (71)
- Induction and differential regulation of bee venom phospholipase A2-specific human IgE and IgG4 antibodies in vitro requires allergen-specific and nonspecific activation of T and B cells. (1997) (70)
- Ozone exposure induces respiratory barrier biphasic injury and inflammation controlled by IL‐33 (2018) (70)
- Clinical practice recommendations for allergen-specific immunotherapy in children: the Italian consensus report (2017) (70)
- Mechanisms of allergen-specific immunotherapy and novel ways for vaccine development. (2013) (69)
- Exploring the repertoire of IgE-binding self-antigens associated with atopic eczema. (2009) (68)
- Pollen exposure weakens innate defense against respiratory viruses (2019) (68)
- Global classification and coding of hypersensitivity diseases – An EAACI – WAO survey, strategic paper and review (2014) (67)
- Prevention and control of childhood asthma and allergy in the EU from the public health point of view: Polish Presidency of the European Union (2012) (67)
- Immune regulation by CD4+CD25+ T cells and interleukin‐10 in birch pollen‐allergic patients and non‐allergic controls (2007) (66)
- Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID‐19 (2020) (66)
- Histamine Upregulates Th1 and Downregulates Th2 Responses due to Different Patterns of Surface Histamine 1 and 2 Receptor Expression (2001) (66)
- Genes of tolerance (2004) (66)
- Respiratory syncytial virus infection influences tight junction integrity (2017) (65)
- miR-146b Probably Assists miRNA-146a in the Suppression of Keratinocyte Proliferation and Inflammatory Responses in Psoriasis. (2017) (65)
- Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases (2019) (65)
- Global Atlas of Allergic Rhinitis and Chronic Rhinosinusitis (2015) (65)
- Suppression of the immune system by oral glucocorticoid therapy in bronchial asthma (1997) (65)
- Future research trends in understanding the mechanisms underlying allergic diseases for improved patient care (2019) (65)
- Asthma, allergy and the Olympics: a 12-year survey in elite athletes (2015) (64)
- Role of IL-10 in allergen-specific immunotherapy and normal response to allergens. (2001) (64)
- Laundry detergents and detergent residue after rinsing directly disrupt tight junction barrier integrity in human bronchial epithelial cells (2019) (64)
- New insights into the role of T cells in atopic dermatitis and allergic contact dermatitis. (2001) (64)
- Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States: An analysis from the EAACI AIT Guidelines Project (2018) (64)
- Vaccines and allergic reactions: The past, the current COVID‐19 pandemic, and future perspectives (2021) (63)
- Particulate Matter 2.5 Causes Deficiency in Barrier Integrity in Human Nasal Epithelial Cells (2019) (63)
- Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma (2020) (62)
- Different natural killer (NK) receptor expression and immunoglobulin E (IgE) regulation by NK1 and NK2 cells (2005) (62)
- Blocking histone deacetylase activity as a novel target for epithelial barrier defects in patients with allergic rhinitis. (2019) (62)
- Defective TCR stimulation in anergized type 2 T helper cells correlates with abrogated p56(lck) and ZAP-70 tyrosine kinase activities. (1997) (61)
- Novel Biologicals for the Treatment of Allergic Diseases and Asthma (2016) (60)
- Histamine receptor 2 is a key influence in immune responses to intestinal histamine-secreting microbes. (2014) (60)
- Restoring airway epithelial barrier dysfunction: a new therapeutic challenge in allergic airway disease. (2017) (59)
- Expression of cutaneous lymphocyte‐associated antigen on human CD4+ and CD8+ Th2 cells (2000) (59)
- Mechanisms of allergen-specific immunotherapy and allergen tolerance. (2020) (59)
- Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma (2020) (59)
- Update in the Mechanisms of Allergen-Specific Immunotheraphy (2010) (59)
- RORC2 Is Involved in T Cell Polarization through Interaction with the FOXP3 Promoter (2010) (59)
- Glucocorticoids inhibit human antigen‐specific and enhance total IgE and IgG4 production due to differential effects on T and B cells in vitro (1997) (58)
- Dual nature of T cell-epithelium interaction in chronic rhinosinusitis. (2009) (58)
- Role of Der p 1–specific B cells in immune tolerance during 2 years of house dust mite–specific immunotherapy (2019) (57)
- Der p 1‐specific regulatory T‐cell response during house dust mite allergen immunotherapy (2019) (56)
- Allergen immunotherapy: a new semantic framework from the European Academy of Allergy and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report (2013) (55)
- ARIA‐EAACI statement on asthma and COVID‐19 (June 2, 2020) (2020) (55)
- Allergen immunotherapy for allergic asthma: a systematic overview of systematic reviews (2017) (54)
- Il-10 producing T and B cells in allergy. (2019) (54)
- ARIA‐EAACI statement on severe allergic reactions to COVID‐19 vaccines – An EAACI‐ARIA Position Paper (2020) (53)
- Connective tissue growth factor expression is regulated by histamine in lung fibroblasts: potential role of histamine in airway remodeling. (2007) (53)
- T-cell regulatory mechanisms in specific immunotherapy. (2008) (53)
- Bacillus Calmette–Guérin‐induced interleukin‐12 did not additionally improve clinical and immunologic parameters in asthmatic children treated with sublingual immunotherapy (2004) (53)
- Serum IL‐5 and IL‐13 consistently serve as the best predictors for the blood eosinophilia phenotype in adult asthmatics (2016) (53)
- Anionic surfactants and commercial detergents decrease tight junction barrier integrity in human keratinocytes. (2016) (51)
- Human NK1 and NK2 subsets determined by purification of IFN-gamma-secreting and IFN-gamma-nonsecreting NK cells. (2002) (51)
- Claudin-1 expression in airway smooth muscle exacerbates airway remodeling in asthmatic subjects. (2011) (51)
- Bypassing IgE and targeting T cells for specific immunotherapy of allergy. (2001) (51)
- Transport of Pru p 3 across gastrointestinal epithelium – an essential step towards the induction of food allergy? (2013) (50)
- European Summit on the Prevention and Self-Management of Chronic Respiratory Diseases: report of the European Union Parliament Summit (29 March 2017) (2017) (50)
- Immune regulation by intralymphatic immunotherapy with modular allergen translocation MAT vaccine (2014) (50)
- Mechanisms of allergen-specific immunotherapy: T-regulatory cells and more. (2006) (49)
- Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5) (2016) (49)
- The IgE-reactive autoantigen Hom s 2 induces damage of respiratory epithelial cells and keratinocytes via induction of IFN-gamma. (2008) (49)
- An altered peptide ligand specifically inhibits Th2 cytokine synthesis by abrogating TCR signaling. (1999) (48)
- The role of environmental factors in allergy: A critical reappraisal (2018) (48)
- Human bocaviruses and paediatric infections. (2019) (48)
- Bacterial secretion of histamine within the gut influences immune responses within the lung (2019) (47)
- Human CD8 T cells of the peripheral blood contain a low CD8 expressing cytotoxic/effector subpopulation (2003) (47)
- Modulation of immune responses by immunotherapy in allergic diseases. (2014) (46)
- Global Allergy Forum and 3rd Davos Declaration 2015 (2016) (46)
- Th2-type cytokine-induced mucus metaplasia decreases susceptibility of human bronchial epithelium to rhinovirus infection. (2014) (46)
- Regulation of TH17 and regulatory T cells in patients with Behçet disease. (2011) (45)
- Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines (2021) (44)
- Human CD40 ligand–expressing type 3 innate lymphoid cells induce IL‐10–producing immature transitional regulatory B cells (2017) (44)
- Increased microRNA‐323‐3p in IL‐22/IL‐17‐producing T cells and asthma: a role in the regulation of the TGF‐β pathway and IL‐22 production (2017) (44)
- T cells and eosinophils in bronchial smooth muscle cell death in asthma (2009) (44)
- Interleukin‐10, T regulatory cells and specific allergy treatment (2004) (44)
- T-cell subsets in the pathogenesis of human asthma (2006) (43)
- Scientific foundations of allergen-specific immunotherapy for allergic disease. (2014) (43)
- Determinants and Mechanisms of Human Immune Responses to Bee Venom Phospholipase A2 (1998) (43)
- EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis. (2017) (42)
- Influenza burden, prevention, and treatment in asthma‐A scoping review by the EAACI Influenza in asthma task force (2018) (42)
- Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies (2020) (42)
- Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies (2020) (42)
- Mechanisms of subcutaneous allergen immunotherapy. (2011) (42)
- T regulatory cells and allergy. (2005) (42)
- SARA and Hgs attenuate susceptibility to TGF‐β 1‐mediated T cell suppression (2003) (41)
- Mechanisms of allergen‐specific immunotherapy (2000) (41)
- Cytokine network and dysregulated apoptosis in atopic dermatitis (2001) (40)
- Relations between epidermal barrier dysregulation and Staphylococcus species–dominated microbiome dysbiosis in patients with atopic dermatitis (2018) (40)
- Histamine in chronic allergic responses. (2005) (40)
- Allergen Immunotherapy in Children User’s Guide (2020) (39)
- Expression of Genes Related to Anti-Inflammatory Pathways Are Modified Among Farmers’ Children (2014) (39)
- Trained immunity and tolerance in innate lymphoid cells, monocytes, and dendritic cells during allergen-specific immunotherapy. (2020) (39)
- Cord Blood Derived CD4+CD25high T Cells Become Functional Regulatory T Cells upon Antigen Encounter (2012) (39)
- Global warming, climate change, air pollution and allergies (2020) (39)
- A novel whole blood gene expression signature for asthma, dermatitis, and rhinitis multimorbidity in children and adolescents (2020) (39)
- Advances and highlights in asthma in 2021 (2021) (39)
- A second step of chemotaxis after transendothelial migration: keratinocytes undergoing apoptosis release IFN-gamma-inducible protein 10, monokine induced by IFN-gamma, and IFN-gamma-inducible alpha-chemoattractant for T cell chemotaxis toward epidermis in atopic dermatitis. (2003) (38)
- The broad spectrum of interepithelial junctions in skin and lung. (2012) (38)
- Exposure to nonmicrobial N‐glycolylneuraminic acid protects farmers' children against airway inflammation and colitis (2018) (38)
- Histamine regulation of innate and adaptive immunity. (2012) (37)
- Decoy receptor-2 small interfering RNA (siRNA) strategy employing three different siRNA constructs in combination defeats adenovirus-transferred tumor necrosis factor-related apoptosis-inducing ligand resistance in lung cancer cells. (2006) (37)
- Regulatory effects of histamine and histamine receptor expression in human allergic immune responses. (2008) (37)
- Epithelial barrier hypothesis: Effect of the external exposome on the microbiome and epithelial barriers in allergic disease (2022) (37)
- Defining adult asthma endotypes by clinical features and patterns of volatile organic compounds in exhaled air (2014) (37)
- T Cell Phenotype in Allergic Asthma and Atopic Dermatitis (2003) (37)
- Role of T cells (2009) (37)
- The relationship of serum vitamins A, D, E and LL-37 levels with allergic status, tonsillar virus detection and immune response (2017) (37)
- Histamine receptor H1 signaling on dendritic cells plays a key role in the IFN-γ/IL-17 balance in T cell-mediated skin inflammation. (2011) (37)
- Regulation of Allergic Inflammation by Skin–Homing T Cells in Allergic Eczema (1999) (36)
- Regulation and expression of IL‐32 in chronic rhinosinusitis (2012) (36)
- Cumulative Lifetime Burden of Cardiovascular Disease From Early Exposure to Air Pollution (2020) (36)
- Novel NLRP3/cryopyrin mutations and pro-inflammatory cytokine profiles in Behçet's syndrome patients. (2014) (36)
- Acute Respiratory Barrier Disruption by Ozone Exposure in Mice (2019) (36)
- Food allergy across the globe. (2021) (36)
- IL-10 Controls Aspergillus fumigatus- and Pseudomonas aeruginosa-Specific T-Cell Response in Cystic Fibrosis (2003) (36)
- Advances and highlights in biomarkers of allergic diseases (2021) (35)
- Atopic asthma after rhinovirus‐induced wheezing is associated with DNA methylation change in the SMAD3 gene promoter (2018) (35)
- Initial butyrate producers during infant gut microbiota development are endospore formers. (2020) (35)
- IgE class switching and cellular memory (2012) (35)
- ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice (2020) (34)
- Mechanisms of Subcutaneous and Sublingual Aeroallergen Immunotherapy: What Is New? (2020) (34)
- Advances and highlights in mechanisms of allergic disease in 2015. (2016) (34)
- Histamine receptor 2 modifies iNKT cell activity within the inflamed lung (2017) (34)
- Distinct regulation of tonsillar immune response in virus infection (2014) (33)
- Impact of systemic immuno‐suppression after solid organ transplantation on allergen‐specific responses (2011) (33)
- CpG-DNA enhances the tight junction integrity of the bronchial epithelial cell barrier. (2015) (33)
- The concepts of asthma endotypes and phenotypes to guide current and novel treatment strategies (2018) (33)
- Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria: A systematic review for the EAACI Biologicals Guidelines (2020) (32)
- A novel proangiogenic B cell subset is increased in cancer and chronic inflammation (2020) (32)
- Current perspective on eicosanoids in asthma and allergic diseases: EAACI Task Force consensus report, part I (2020) (31)
- Specific immunotherapy and turning off the T cell: how does it work? (2011) (31)
- Histamine Receptor 2 is Required to Suppress Innate Immune Responses to Bacterial Ligands in Patients with Inflammatory Bowel Disease (2016) (31)
- Mechanisms of Aeroallergen Immunotherapy: Subcutaneous Immunotherapy and Sublingual Immunotherapy. (2016) (31)
- The expression of gingival epithelial junctions in response to subgingival biofilms (2015) (30)
- Role of dysregulated apoptosis in atopic dermatitis (2000) (30)
- Differential expression of IL-33 and HMGB1 in the lungs of stable cystic fibrosis patients (2014) (30)
- Biologicals in atopic disease in pregnancy: An EAACI position paper (2020) (30)
- Human rhinoviruses enter and induce proliferation of B lymphocytes (2017) (30)
- Chemiluminescent and enzyme-linked immuno assays for sensitive detection of human IFN-gamma. (1994) (29)
- Differentiation of COVID‐19 signs and symptoms from allergic rhinitis and common cold: An ARIA‐EAACI‐GA2LEN consensus (2021) (29)
- Novel immunotherapy vaccine development (2014) (29)
- Clinical Overview of Cutaneous Features in Hypereosinophilic Syndrome (2012) (28)
- Regulatory cells in allergen-specific immunotherapy. (2012) (28)
- Intranasal Bifidobacterium longum protects against viral-induced lung inflammation and injury in a murine model of lethal influenza infection (2020) (28)
- Altered fatty acid metabolism and reduced stearoyl‐coenzyme a desaturase activity in asthma (2017) (28)
- Allergology in Europe, the blueprint (2013) (28)
- Monitoring inflammatory heterogeneity with multiple biomarkers for multidimensional endotyping of asthma. (2018) (27)
- Validation of the Global Allergy and Asthma European Network (GA2LEN) chamber for trials in allergy: Innovation of a mobile allergen exposure chamber (2017) (27)
- Histamine receptors in immune regulation and allergen-specific immunotherapy. (2006) (27)
- Global Allergy Forum and Second Davos Declaration 2013 Allergy: Barriers to cure – challenges and actions to be taken (2014) (27)
- Recent developments and advances in atopic dermatitis and food allergy. (2020) (27)
- Suppression of B‐cell activation and IgE, IgA, IgG1 and IgG4 production by mammalian telomeric oligonucleotides (2013) (27)
- Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic (2020) (27)
- Mechanisms of immune tolerance to allergens in children (2013) (26)
- Myocardial expression profiles of candidate molecules in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia compared to those with dilated cardiomyopathy and healthy controls. (2016) (26)
- Precision medicine and precision health: Building blocks to foster a revolutionary health care model. (2016) (26)
- Chronic rhinosinusitis: pathogenesis, therapy options, and more (2018) (25)
- Cellular and molecular mechanisms of allergic asthma. (2021) (25)
- A review of the value of innovation in inhalers for COPD and asthma (2015) (25)
- IL-10 suppresses CD2-mediated T cell activation via SHP-1. (2009) (25)
- Allergen immunotherapy for IgE‐mediated food allergy: There is a measure in everything to a proper proportion of therapy (2019) (25)
- Potential Interplay between Nrf2, TRPA1, and TRPV1 in Nutrients for the Control of COVID-19 (2021) (25)
- Management of patients with chronic rhinosinusitis during the COVID‐19 pandemic—An EAACI position paper (2020) (25)
- Direct assessment of skin epithelial barrier by electrical impedance spectroscopy (2019) (25)
- In vitro induction of functional allergen‐specific CD4+ CD25high Treg cells in horses affected with insect bite hypersensitivity (2013) (25)
- The role of Treg cell subsets in allergic disease. (2020) (24)
- Mechanisms of immune tolerance to allergens. (2017) (24)
- World Health Organization global air quality guideline recommendations: Executive summary (2021) (24)
- Efficacy and safety of dupilumab for moderate‐to‐severe atopic dermatitis: A systematic review for the EAACI biologicals guidelines (2020) (24)
- T Regulatory Cells in Allergen-Specific Immunotherapy (2005) (24)
- Impaired memory B‐cell development and antibody maturation with a skewing toward IgE in patients with STAT3 hyper‐IgE syndrome (2019) (24)
- T-cell regulation during viral and nonviral asthma exacerbations. (2015) (24)
- The Induction of IL-33 in the Sinus Epithelium and Its Influence on T-Helper Cell Responses (2015) (23)
- Mechanisms of allergen-specific immunotherapy. (2000) (23)
- Comparison of Der p1‐specific antibody levels in children with allergic airway disease and healthy controls (2007) (23)
- Human type 2 innate lymphoid cells disrupt skin keratinocyte tight junction barrier by IL‐13 (2019) (23)
- Staphylococcus aureus enhances the tight junction barrier integrity in healthy nasal tissue, but not in nasal polyps. (2018) (23)
- Consensus Communication on Early Peanut Introduction and Prevention of Peanut Allergy in High‐Risk Infants (2016) (23)
- Modular antigen-translocation as a novel vaccine strategy for allergen-specific immunotherapy (2009) (23)
- FcεRI stimulation promotes the differentiation of histamine receptor 1‐expressing inflammatory macrophages (2013) (23)
- Exopolysaccharide from Bifidobacterium longum subsp. longum 35624™ modulates murine allergic airway responses. (2018) (23)
- Gene expression signatures of circulating human type 1, 2, and 3 innate lymphoid cells. (2019) (23)
- We Call for iCAALL: International Collaboration in Asthma, Allergy and Immunology (2012) (22)
- The suppressive role of IL-10 in contact and atopic dermatitis. (2012) (22)
- Are regulatory T cells the target of venom immunotherapy? (2005) (22)
- Impact of high‐altitude therapy on type‐2 immune responses in asthma patients (2019) (22)
- Plasma interleukin-1α, interleukin-1β and interleukin-1 receptor antagonist levels in pre-eclampsia (1997) (22)
- The Global Alliance against Respiratory Diseases (GARD) Country Report (2014) (21)
- Development and characterization of DNAzyme candidates demonstrating significant efficiency against human rhinoviruses (2018) (21)
- TRAIL Death Receptor-4, Decoy Receptor-1 and Decoy Receptor-2 Expression on CD8+ T Cells Correlate with the Disease Severity in Patients with Rheumatoid Arthritis (2010) (21)
- The phosphatidylinositol phosphatase PTEN is under control of costimulation and regulates proliferation in human T cells (2002) (21)
- Climate change and global health: A call to more research and more action (2022) (21)
- Role of T cells and cytokines in the intrinsic form of atopic dermatitis. (1999) (21)
- Allergen immunotherapy in the current COVID-19 pandemic: A position paper of AeDA, ARIA, EAACI, DGAKI and GPA (2020) (21)
- Unraveling the complexity of atopic dermatitis: The CK‐CARE approach toward precision medicine (2020) (21)
- COVID‐19 vaccine anaphylaxis: IgE, complement or what else? A reply to: “COVID‐19 vaccine anaphylaxis: PEG or not?” (2021) (20)
- Electrical impedance spectroscopy for the characterization of skin barrier in atopic dermatitis (2021) (20)
- Cutaneous and systemic hyperinflammation drives maculopapular drug exanthema in severely ill COVID‐19 patients (2021) (20)
- Role of Apoptosis in Atopic Dermatitis (2001) (20)
- Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies (2016) (20)
- The epithelial barrier hypothesis proposes a comprehensive understanding of the origins of allergic and other chronic non-communicable diseases. (2021) (20)
- Primate segmental duplication creates novel promoters for the LRRC37 gene family within the 17q21.31 inversion polymorphism region (2012) (20)
- T cells in health and disease. (2009) (20)
- Are regulatory T cells the target of venom immunotherapy (2005) (19)
- The expression of cannabinoid receptor 1 is significantly increased in atopic patients. (2014) (19)
- Tonsillar cytokine expression between patients with tonsillar hypertrophy and recurrent tonsillitis (2018) (19)
- Transforming growth factor-β1 decreases epithelial tight junction integrity in chronic rhinosinusitis with nasal polyps. (2017) (19)
- The effect of CD14 C159T polymorphism on in vitro IgE synthesis and cytokine production by PBMC from children with asthma (2011) (19)
- A Fluorescent Probe to Unravel Functional Features of Cannabinoid Receptor CB1 in Human Blood and Tonsil Immune System Cells. (2018) (19)
- Allergen immunotherapy for allergic asthma: protocol for a systematic review (2016) (19)
- New insights into mechanisms of immunoregulation in 2007. (2008) (19)
- Comparison of regulatory B cells in asthma and allergic rhinitis (2019) (19)
- Bacillus Calmette-Guerin, Mycobacterium bovis, as an immunomodulator in atopic diseases. (2006) (19)
- Distinct expression of SARS‐CoV‐2 receptor ACE2 correlates with endotypes of chronic rhinosinusitis with nasal polyps (2020) (19)
- Role of bacillus Calmette–Guérin as an immunomodulator for the prevention and treatment of allergy and asthma (2005) (18)
- T cells and effector mechanisms in the pathogenesis of atopic dermatitis (2002) (18)
- Consensus Communication on Early Peanut Introduction and the Prevention of Peanut Allergy in High-risk Infants (2015) (18)
- Allergen immunotherapy for IgE-mediated food allergy: protocol for a systematic review (2016) (18)
- miR‐10a‐5p is increased in atopic dermatitis and has capacity to inhibit keratinocyte proliferation (2019) (18)
- Future of allergen-specific immunotherapy: better understanding of the mechanisms, novel treatments, and long-term cure. (2006) (17)
- Immune response modifiers in the treatment of asthma: A PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology. (2012) (17)
- Highlights of Novel Vaccination Strategies in Allergen Immunotherapy. (2020) (17)
- Spermidine and spermine exert protective effects within the lung (2021) (17)
- Nanoparticle-coupled topical methotrexate can normalize immune responses and induce tissue remodeling in psoriasis. (2020) (17)
- The many routes of dendritic cells to ensure immune regulation. (2011) (16)
- 94 – Histamine and H1 Antihistamines (2014) (16)
- Important questions in allergy: novel research areas (2008) (16)
- A novel, dual cytokine‐secretion assay for the purification of human Th22 cells that do not co‐produce IL‐17A (2016) (16)
- Precision/Personalized Medicine in Allergic Diseases and Asthma (2018) (16)
- Highlights in immune response, microbiome and precision medicine in allergic disease and asthma. (2017) (16)
- Spices to Control COVID-19 Symptoms: Yes, but Not Only… (2020) (16)
- Allergen immunotherapy for IgE-mediated food allergy (2017) (15)
- In utero priming by worms protects against respiratory allergies. (2014) (15)
- Histamine as an immune modulator in chronic inflammatory responses (2007) (15)
- Allergen immunotherapy for insect venom allergy: protocol for a systematic review (2016) (15)
- Differential serum protein markers and the clinical severity of asthma (2014) (15)
- Introduction to Mechanisms of Allergic Diseases (2022) (15)
- Novel immunotherapeutic approaches for allergy and asthma (2010) (15)
- Mechanisms of Allergen Immunotherapy (2004) (15)
- Immune regulation by histamine H4 receptors in skin. (2008) (14)
- Back to the future: Antibody-based strategies for the treatment of infectious diseases (2002) (14)
- Skin barrier damage after exposure to para-phenylenediamine. (2019) (14)
- The form of PEG matters: PEG conjugated with lipids and not PEG alone could be the specific form involved in allergic reactions to COVID‐19 vaccines (2021) (14)
- Skin homing (CLA+) T cells in atopic dermatitis spontaneously secrete an IL-13 dominated Th2 cytokine pattern and induce IgE production. IgG4 counter-regulation by CLA− T cells (1997) (14)
- Outside-in hypothesis revisited: the role of microbial, epithelial and immune interactions. (2020) (14)
- Dysregulation of the epithelial barrier by environmental and other exogenous factors (2021) (14)
- Role of dietary fiber in promoting immune health—An EAACI position paper (2021) (13)
- Monkeypox outbreak in Europe, UK, North America, and Australia: A changing trend of a zoonotic disease (2022) (13)
- Targets in allergy-directed immunotherapy (2005) (13)
- Cannabinoids induce functional Tregs by promoting tolerogenic DCs via autophagy and metabolic reprograming (2021) (13)
- Polymorphisms of endotoxin pathway and endotoxin exposure: in vitro IgE synthesis and replication in a birth cohort (2014) (13)
- Severe asthma: Entering an era of new concepts and emerging therapies: Highlights of the 4th international severe asthma forum, Madrid, 2018 (2019) (13)
- Plasma interleukin-1alpha, interleukin-1beta and interleukin-1 receptor antagonist levels in pre-eclampsia. (1997) (13)
- Fighting allergies beyond symptoms: The European Declaration on Immunotherapy (2011) (13)
- Immunological methods for diagnosis and monitoring of IgE‐mediated allergy caused by industrial sensitizing agents (IMExAllergy) (2019) (12)
- Innate lymphoid cells: The missing part of a puzzle in food allergy (2020) (12)
- WAO International Scientific Conference (WISC 2016) Abstracts (2017) (12)
- T‐cell and antibody responses to phospholipase A2 from different species show distinct cross‐reactivity patterns (2011) (12)
- Highlights and recent developments in airway diseases in EAACI journals (2018) (2019) (12)
- Climate change: A call to action for the United Nations (2021) (12)
- Tolerance mechanisms in allergen immunotherapy (2020) (11)
- microRNA‐146a is linked to the production of IgE in mice but not in atopic dermatitis patients (2018) (11)
- Allergy and the Immunologic Basis of Atopic Disease (2011) (11)
- An Exopolysaccharide Produced by Bifidobacterium longum 35624® Inhibits Osteoclast Formation via a TLR2-Dependent Mechanism (2021) (11)
- Management of anaphylaxis due to COVID‐19 vaccines in the elderly (2021) (11)
- The effect of allergy and asthma as a comorbidity on the susceptibility and outcomes of COVID-19 (2021) (11)
- Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (2020) (10)
- Innate mechanisms can predict successful allergy immunotherapy. (2016) (10)
- Building the investment case for asthma R&D: the European Asthma Research and Innovation Partnership argument (2016) (10)
- Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (2020) (10)
- Nature of Regulatory T Cells in the Context of Allergic Disease (2008) (10)
- EAACI Biologicals Guidelines—dupilumab for children and adults with moderate‐to‐severe atopic dermatitis (2020) (10)
- ARIA‐EAACI care pathways for allergen immunotherapy in respiratory allergy (2021) (10)
- Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants. (2018) (10)
- Under the skin or under the tongue: differences and similarities in mechanisms of sublingual and subcutaneous immunotherapy. (2013) (9)
- Advances in Immunological Treatment of Allergy (2003) (9)
- Provocative proposal for a revised nomenclature for allergy and other hypersensitivity diseases (2018) (9)
- COVID‐19: A series of important recent clinical and laboratory reports in immunology and pathogenesis of SARS‐CoV‐2 infection and care of allergy patients (2020) (9)
- Future of allergen-specific immunotherapy (2005) (9)
- We call for iCAALL: International Collaboration in Asthma, Allergy and Immunology. (2012) (9)
- Immunologic mechanisms of allergen-specific immunotherapy. (2001) (9)
- Advances in allergen-specific immunotherapy (2005) (9)
- Highlights and recent developments in food and drug allergy, and anaphylaxis in EAACI Journals (2017) (2018) (9)
- Highlights and recent developments in skin allergy and related diseases in EAACI journals (2018) (2019) (8)
- Novel developments in the mechanisms of immune tolerance to allergens (2012) (8)
- Highlights and recent developments in airway diseases in EAACI journals (2017) (2018) (8)
- T Cells and Effector Functions in Atopic Dermatitis (2002) (8)
- Early suppression of basophil activation during allergen-specific immunotherapy by upregulation of histamine receptor 2 (2007) (8)
- Asthma research in Europe: a transformative agenda for innovation and competitiveness (2017) (8)
- Gut microbial-derived short-chain fatty acids and bone: a potential role in fracture healing. (2021) (8)
- Segmental duplications and evolutionary acquisition of UV damage response in the SPATA31 gene family of primates and humans (2017) (8)
- Inhibition of CpG methylation improves the barrier integrity of bronchial epithelial cells in asthma (2020) (8)
- Platelet-activating factor decreases skin keratinocyte tight junction barrier integrity. (2016) (8)
- [Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI-AeDA-GPA-DGAKI Position Paper (Pocket-Guide)]. (2020) (8)
- Davos declaration: Allergy as a global problem (Allergy: European Journal of Allergy and Clinical Immunology (2012) 67, (141-143)) (2012) (8)
- Key Points for Moving the Endotypes Field Forward (2019) (7)
- The cannabinoid WIN55212‐2 restores rhinovirus‐induced epithelial barrier disruption (2020) (7)
- Butyrate Inhibits Osteoclast Activity In Vitro and Regulates Systemic Inflammation and Bone Healing in a Murine Osteotomy Model Compared to Antibiotic-Treated Mice (2021) (7)
- [How does eczema arise?]. (2003) (7)
- Sulforaphane: from death rate heterogeneity in countries to candidate for prevention of severe COVID-19 (2020) (7)
- Alpine altitude climate treatment for severe and uncontrolled asthma: An EAACI position paper (2022) (7)
- Mechanisms of specific immunotherapy: current knowledge. (2003) (7)
- Prostaglandin E2 and lipoxin A4 in PBMCs are associated with immune tolerance during venom immunotherapy. (2016) (7)
- Non–immunoglobulin E-mediated allergy associated with Pfizer-BioNTech coronavirus disease 2019 vaccine excipient polyethylene glycol (2021) (7)
- EAACI Biologicals Guidelines—Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12–17 years old (2021) (6)
- Title Genome analysis and characterisation of the exopolysaccharide produced by Bifidobacterium longum subsp . longum 35624 TM (2018) (6)
- Pimecrolimus, a topical calcineurin inhibitor used in the treatment of atopic eczema (2013) (6)
- Discontinued drugs in 2006: pulmonary-allergy, dermatological, gastrointestinal and arthritis drugs (2007) (6)
- Machine Learning-Based Deep Phenotyping of Atopic Dermatitis: Severity-Associated Factors in Adolescent and Adult Patients. (2021) (6)
- Is the epithelial barrier hypothesis the key to understanding the higher incidence and excess mortality during COVID‐19 pandemic? The case of Northern Italy (2022) (6)
- Loss of regulatory capacity in T regulatory cells upon rhinovirus infection. (2021) (6)
- Environment‐dependent alterations of immune mediators in urban and rural South African children with atopic dermatitis (2021) (6)
- CRC desk reference for allergy and asthma (2000) (6)
- COVID‐19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals—EAACI recommendations (2022) (5)
- Food and drug allergy, and anaphylaxis in EAACI journals (2018) (2019) (5)
- Direct platelet adhesion potentiates group 2 innate lymphoid cell functions (2021) (5)
- COVID‐19 vaccines and the role of other potential allergenic components different from PEG. A reply to: “Other excipients than PEG might cause serious hypersensitivity reactions in COVID‐19 vaccines” (2021) (5)
- The underlying mechanisms in allergy (2014) (5)
- Recent advances and developments in COVID‐19 in the context of allergic diseases (2021) (5)
- Experimental rhinovirus infection induces an antiviral response in circulating B cells which is dysregulated in patients with asthma (2021) (5)
- Characterization and regulation of microplastic pollution for protecting planetary and human health. (2022) (5)
- The abundance of Ruminococcus bromii is associated with faecal butyrate levels and atopic dermatitis in infancy (2022) (5)
- Acknowledgment of Reviewers, 2016 (2016) (5)
- We call for iCAALL: International Collaboration in Asthma, Allergy and Immunology (2012) (5)
- Recent developments in the immunopathology of COVID‐19 (2022) (5)
- Differential regulation of allergen-specific antibodies in allergy and specific immunotherapy. (1999) (4)
- Blocking Histone Deacetylase Activity As A Novel Target For Epithelial Barrier Defects In Allergic Rhinitis: 261 (2019) (4)
- Mechanisms of Allergic Skin Inflammation (2002) (4)
- Persistent human bocavirus 1 infection and tonsillar immune responses (2021) (4)
- Highlights and recent developments in allergic diseases in EAACI journals (2019) (2020) (4)
- Influence of Innate Immunity on Immune Tolerance. (2020) (4)
- Trigeminal endonasal perception - an outcome predictor for septoplasty. (2020) (4)
- Rhinovirus triggers increased inflammasome activation in human bronchial epithelium in asthma (2017) (4)
- Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5) (2017) (4)
- The External Exposome and Allergies: From the Perspective of the Epithelial Barrier Hypothesis (2022) (4)
- Mechanisms of allergen-specific immunotherapy. (2006) (4)
- Mesenchymal stromal cells‐derived small extracellular vesicles modulate DC function to suppress Th2 responses via IL‐10 in patients with allergic rhinitis (2022) (4)
- Rhinovirus species and tonsillar immune responses (2019) (4)
- Differentiation of bronchial epithelial spheroids in the presence of IL‐13 recapitulates characteristic features of asthmatic airway epithelia (2022) (3)
- Multidimensional endotyping using nasal proteomics predicts molecular phenotypes in the asthmatic airways. (2022) (3)
- Leukocyte redistribution as immunological biomarker of corticosteroid resistance in severe asthma (2022) (3)
- Epithelial barrier hypothesis and the development of allergic and autoimmune diseases (2022) (3)
- T regulatory cells from atopic asthmatic individuals show a Th2‐like phenotype (2021) (3)
- Mechanisms and biomarkers of successful allergen-specific immunotherapy (2022) (3)
- T cell requirement and phenotype stability of house dust mite–induced neutrophil airway inflammation in mice (2020) (3)
- Current perspectives T H 17 cells in the big picture of immunology (2007) (3)
- Increased antiviral response in circulating lymphocytes from hypogammaglobulinemia patients (2020) (3)
- Physical activity in asthma control and its immune modulatory effect in asthmatic preschoolers (2021) (3)
- ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines -- an EAACI-ARIA Position Paper (2020) (3)
- Mise à jour sur l’immunothérapie allergénique : Rapport de Consensus PRACTALL de l’AAAAI (American Academy of Allergy, Asthma and Immunology) et de l’EAACI (European Academy of Allergy and Clinical Immunology) ☆ (2014) (3)
- Mesenchymal stem cells regulate type 2 innate lymphoid cells via regulatory T cells through ICOS‐ICOSL interaction (2021) (3)
- Tonsillar microbial diversity, abundance, and interrelations in atopic and non‐atopic individuals (2020) (3)
- Eczematous dermatitis : T cell and keratinocyte apoptosis plays a key pathogenetic (2018) (3)
- A compendium answering over 140 questions on COVID-19 and SARS-CoV-2 (2020) (3)
- Involvement and therapeutic implications of airway epithelial barrier dysfunction in type 2 inflammation of asthma (2022) (3)
- Gut epithelial barrier damage caused by dishwasher detergents and rinse aids. (2022) (3)
- The cannabinoid WIN55212‐2 suppresses effector T‐cell responses and promotes regulatory T cells in human tonsils (2021) (3)
- Regulation of Allergic Inflammation by T Cells and Cytokines in Atopic Dermatitis (2001) (3)
- The effects of cryopreservation on the expression of canine regulatory T‐cell markers (2017) (3)
- EUFOREA Rhinology Research Forum 2017: report of the brainstorming sessions on endotype-driven treatment, patient empowerment and digital future in airways care (2018) (3)
- Highlights in Cellular and Molecular Mechanisms of Allergic Diseases (2006) (3)
- EAACI Research and Outreach Committee: Improving standards and facilitating global collaboration through a Research Excellence Network (2020) (3)
- Epitope-specific T cell tolerance to phospholipase A2 in bee venom and peptide immunotherapy. Recovery by IL-2 and IL-15 in vitro (1997) (2)
- Transfer and loss of allergen‐specific responses via stem cell transplantation: A prospective observational study (2020) (2)
- The influence of corticosteroids and Azelastine on epithelial cell integrity in chronic rhinosinusitis with polyps (2020) (2)
- Increased circulating CRTH2+Tregs are associated with asthma control and exacerbation (2021) (2)
- Immunological basis of specific immunotherapy in IgE-mediated allergic reactions (2001) (2)
- Increased circulating CRTH2 + Tregs are associated with asthma control and exacerbation (2021) (2)
- A new beginning: Building on the past, looking to the future. (2016) (2)
- GA2LEN (Global Allergy and Asthma European Network), die Perspektive der deutschsprachigen Zentren (2009) (2)
- T Cells and Effector Mechanisms in Atopic Dermatitis (2002) (2)
- Cannabinoid WIN55212‐2 impairs peanut‐allergic sensitization and promotes the generation of allergen‐specific regulatory T cells (2022) (2)
- Atopic dermatitis in a cohort of West Highland white terriers in Switzerland. Part II: estimates of early life factors and heritability. (2020) (2)
- Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: a systematic review for the EAACI Biologicals Guidelines (2020) (2)
- Allergen immunotherapy in the current COVID-19 pandemic - A position paper of the AeDA, ARIA, EAACI, DGAKI and GPA (2020) (2)
- A compilation answering 50 questions on monkeypox virus and the current monkeypox outbreak (2023) (2)
- Research needs in allergy (2012) (2)
- Mouse Models of Asthma: Characteristics, Limitations and Future Perspectives on Clinical Translation. (2021) (2)
- COVID‐19 vaccines—The way forward (2021) (2)
- [Principles of specific immunotherapy of IgE-induced allergic reactions]. (2001) (2)
- Precision Medicine in Allergic Disorders (2017) (2)
- Induction of Blocking Antibodies with T Cell Epitope-Containing Hypoallergenic Recombinant Bet v 1 Fragments (2001) (2)
- Regulation of angiotensin-converting enzyme 2 isoforms by type 2 inflammation and viral infection in human airway epithelium (2023) (2)
- Antibody-based therapies in infectious diseases. (2000) (2)
- [Evaluation of the ELISA method for the diagnosis of Helicobacter pylori]. (1993) (2)
- Inhaled corticosteroids in early COVID‐19—A tale of many facets (2021) (2)
- Specific allergy and asthma prevention coming to an age: A milestone in children. (2017) (2)
- Asthma, allergy and the Olympics (2015) (2)
- The future of allergy/immunology: Promising young investigators. (2017) (2)
- Desert dust and respiratory diseases: Further insights into the epithelial barrier hypothesis (2022) (2)
- Allergy: Mechanistic insights into new methods of prevention and therapy (2023) (2)
- The Editors' Choice. (2022) (2)
- Evanescence wave-based technology for the rapid and sensitive quantification of biological analytes. (2017) (2)
- Loss of food fermentation in Westernized diet: a risk factor for severe COVID-19? (2020) (2)
- Effect of altered human exposome on the skin and mucosal epithelial barrier integrity. (2022) (2)
- Effects of non‐steroidal anti‐inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID‐19 (2021) (1)
- Monitoring the inflammatory heterogeneity in asthma with multiple biomarkers for multidimensional endotyping (2017) (1)
- Type 3 innate lymphoid cells induce proliferation of CD94+ natural killer cells. (2017) (1)
- COVID-19 vaccines and the role of other potential allergenic components different from PEG. (2021) (1)
- The past, present, and future of allergic diseases in China (2022) (1)
- T helper (Th) 2 predominance in atopy is due to preferential Th1 memory/effector cell apoptosis (2003) (1)
- Pathophysiology of Allergic Rhinitis (2019) (1)
- The inspirational journey of Chinese scholars in the field of allergy (2020) (1)
- Enhancing Data Reliability in TOMAHAQ for Large‐Scale Protein Quantification (2020) (1)
- Monkeypox and other zoonotic poxviruses (2022) (1)
- Interleukins , from 1 to 38 , interferons , transforming growth factor-and tumor necrosis factor-alpha : receptors , functions and roles in diseases (2017) (1)
- Spermidine ameliorates colitis via induction of anti-inflammatory macrophages and prevention of intestinal dysbiosis. (2023) (1)
- World Allergy Forum Symposium: New Insights Into Immunotherapy for Allergic Disorders (2009) (1)
- Rhinovirus infection has allergen-specific tolerance-breaking effects on PBMCs of healthy individuals (2015) (1)
- Exposure to avian coronavirus vaccines is associated with increased levels of SARS‐CoV‐2‐cross‐reactive antibodies (2022) (1)
- Immunology: Paper alert (2001) (1)
- Reviewers for the Journal, January-June 2016. (2016) (1)
- MOESM1 of Allergen immunotherapy for IgE-mediated food allergy: protocol for a systematic review (2016) (1)
- IL-33 receptor expression on myeloid and plasmacytoid dendritic cells after allergen challenge in patients with allergic rhinitis. (2021) (1)
- Human and planetary health on fire (2022) (1)
- In vitro induction of functional allergen-specific CD4(+)CD25(high) Treg cells in horses affected with insect bite (2013) (1)
- International consensus statement on allergy and rhinology: Allergic rhinitis – 2023 (2023) (1)
- This information is current as Abrogating TCR Signaling Inhibits Th 2 Cytokine Synthesis by An Altered Peptide Ligand Specifically (1999) (1)
- Mechanisms of immune regulation in allergic rhinitis (2015) (1)
- Inhibition of CpG methylation improves the barrier integrity of bronchial epithelial cells in asthma. (2020) (1)
- We call for iCAALL: International Collaboration for Asthma, Allergy and Immunology. (2012) (1)
- Key role of regulatory cytokines TGF-β and IL-10 as well as allergen-specific IgA and IgG4 in tolerance to mucosal antigens/allergens (2002) (1)
- Allergic reactions to the first COVID-19 vaccine: a potential role of Polyethylene glycol? (2020) (1)
- Chronic inflammatory responses in the lungs of CF-patients: Th17 cells play a crucial role (2010) (0)
- Transferability and curability of allergic disease by allogeneic hematopoietic stem cell transplantation (2020) (0)
- Oral Abstract presentations 09 : 20-11 : 00 Innate Immune Responses O 01 Carbohydrate A 10 ( CA 10 ) From Ehrlich Tumor Cells Promote Tolerance By Acting On Human Dendritic Cells And Generating Functional Regulatory T Cells (2017) (0)
- Is exposure to pollen a risk factor for moderate and severe asthma exacerbations? (2023) (0)
- Development of antirhinoviral DNAzymes for effective prevention of asthma exacerbations: 299 (2019) (0)
- MOESM1 of Allergen immunotherapy for allergic asthma: protocol for a systematic review (2016) (0)
- The Editors' Choice. (2021) (0)
- Atopic dermatitis: correlation of distinct risk factors with age of onset in adulthood compared to childhood. (2023) (0)
- IL-33 and Inflammatory Responses in Allergic Diseases (2013) (0)
- Skin Immune System: T cells (2019) (0)
- 4 – Immune Tolerance (2014) (0)
- IS2-1 Effector and Regulatory T cells in Allergy(Session 2: Novel Roles of Inflammatory Cells,Eosinophils, other Inflammatory Cells and Molecules in Allergy) (2009) (0)
- Specific IgE and diagnosis of allergic rhinitis (2015) (0)
- The Editors' Choice. (2016) (0)
- Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis (2017) (0)
- The short-term and long-term effects of intranasal mesenchymal stem cell administration to noninflamed mice lung (2022) (0)
- Understanding the Association of IgE and Gut and Mucosal Proteins in Atopic Disorders (2022) (0)
- Acknowledgements (2006) (0)
- The Editors' Choice. (2018) (0)
- Assessing Different Feature Selection Methods Applied to a Bulk RNA Sequencing Dataset with Regard to Biomedical Relevance (2022) (0)
- Atopic eczema and allergies: Practical relevance for diagnostic work-up (2013) (0)
- Antigen-Specific T Cell Responses Regulatory NK Cells Suppress (2007) (0)
- Comprehensive characterization of asthma patients using the Bayesian Network Model (2017) (0)
- Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria- a systematic review for the EAACI Biologicals Guidelines (2020) (0)
- The Editors' Choice. (2021) (0)
- Iconographies supplémentaires de l'article : International consensus on allergy immunotherapy (2015) (0)
- iCAALL: International Collaboration in Asthma, Allergy and Immunology (2014) (0)
- Mechanisms of immune-tolerance to allergens on the mucosal surfaces (2011) (0)
- Sputum Cytokines and Adult Asthma Endotypes (2014) (0)
- A Novel Human Effector B cell Subset (2017) (0)
- Specific peptide immunotherapy (2000) (0)
- Importance of examining atopic dermatitis disease mechanisms in African populations (2022) (0)
- Production in Atopic Dermatitis Contribute to Eosinophilia and IgE T Cells Respond to Superantigen and + CD 8 Lymphocyte-Associated Antigen-Positive ) Skin Homing ( Cutaneous (1999) (0)
- In lasting tribute: Professor Dr Işil Berat Barlan (1958-2015) (2015) (0)
- The Editors' Choice. (2016) (0)
- 096 Transcriptomic analysis of epidermal barrier molecules, cytokines and growth factors in atopic dermatitis lesions (2016) (0)
- Precision/Personalized Medicine in Allergic Diseases and Asthma (2018) (0)
- Phospholipase A2-and hyaluronidase-specific IgG4 defines allergenicity and/or hyperimmunity to bee venom (2003) (0)
- EAACI Guidelines on environmental science in allergic diseases and asthma - leveraging artificial intelligence and machine learning to develop a causality model in exposomics. (2023) (0)
- Epithelial Barrier Hypothesis and Its Comparison with the Hygiene Hypothesis (2023) (0)
- Epithelial Genes in Allergic Inflammation (2018) (0)
- Distinctive gene signature of allergen-specific CD4+T cells in allergic patients (2017) (0)
- Asthma – chronic obstructive pulmonary disease overlap syndrome ( ACOS ) in patients with perinatal HIV infection ? (2017) (0)
- The Editors' Choice. (2022) (0)
- The Editors' Choice. (2017) (0)
- 4932Identification of novel biomarkers for diagnosis of arrhythmogenic right ventricular cardiomyopathy using transcriptomics and label-free proteomics (2018) (0)
- 136 MiR-10a controls the proliferation and inflammatory responses of human primary keratinocytes. MiR-10a controls the proliferation and inflammatory responses of human primary keratinocytes (2016) (0)
- EAACI Fellowship Awards Final Report (2018) (0)
- Mechanisms of peripheral T cell tolerance during natural exposure to bee stings and mucosal allergens, house-dust mite and birch pollen in healthy individuals (2002) (0)
- Subject Index Vol. 131, 2003 (2003) (0)
- T regulatory cells from asthmatic individuals show a Th2-like phenotype (0)
- PS1-2 Healthy and allergic immune response to aeroallergens(Part-1 "Allergens and immune responses",New approach to treatment of allergic diseases,English session) (2007) (0)
- 316 MicroRNA miR-146a reduces psoriasis-associated inflammatory responses in keratinocytes (2016) (0)
- Contents Vol. 131, 2003 (2003) (0)
- The Editors' Choice. (2016) (0)
- Segmental duplications and evolutionary acquisition of UV damage response in the SPATA31 gene family of primates and humans (2017) (0)
- Tonsillar transcriptional profiles in atopic and non‐atopic subjects (2022) (0)
- The underlying mechanisms in allergic rhinitis (2015) (0)
- Immunologic Mechanisms of Novel Allergen-Specific Immunotherapies (2016) (0)
- Issue Information (2021) (0)
- Use of biologics in allergic and type 2 inflammatory diseases in the current Covid 19 pandemic(a, b, c) (2020) (0)
- Mechanisms of Subcutaneous and Sublingual Aeroallergen Immunotherapy (2020) (0)
- Syddansk Universitet Validation of the GA ( 2 ) LEN chamber for trials in allergy Innovation of a mobile allergen exposure chamber (0)
- ORAL PRESENTATIONS O 1 Local allergic rhinitis : natural history (2013) (0)
- Epithelium in Allergic Diseases (2018) (0)
- Kimchi and Asian fermented vegetables: candidates for the partial control of the COVID-19 pandemic (2020) (0)
- IL3 Molecular and cellular mechanisms of chronicity in asthma (2014) (0)
- Low Levels of Cytokines and Growth Factors in Serum of Allergic and Non-Allergic Top Atletes (2011) (0)
- Resolving the aetiology and treatments of allergic diseases. (2023) (0)
- The Editors' Choice. (2019) (0)
- Cytokine expression in rhinovirus- vs. respiratory syncytial virus-induced first wheezing episode and its relation to clinical course (2022) (0)
- The role of allied health in the management of allergic diseases (2014) (0)
- Contents Vol. 121, 2000 (2000) (0)
- SOCIO-ECONOMIC STATUS AND THE PREVALENCE OF FOOD SENSITISATION AND FOOD ALLERGY IN URBAN CAPE TOWN CHILDREN (0)
- Respiratory virome profiles reflect antiviral immune responses (2023) (0)
- List of Contributors (2019) (0)
- The Editors' Choice. (2016) (0)
- Accepting a Manuscript: What Do Editors Look for? (2018) (0)
- Skin homing T cells. (2004) (0)
- The Editors' Choice. (2017) (0)
- 28 – Immunology of the Asthmatic Response (2016) (0)
- From gene expression measurements to epidemiological studies (2015) (0)
- Soluble mediators derived from bronchial epithelium are able to drive Th2 differentiation in the context of rhinovirus infection (2013) (0)
- The Editors' Choice. (2017) (0)
- JACI: Year-in-Review (2016) (0)
- The Editors' Choice. (2017) (0)
- Detection of Gut and Mucosal Peptides through TOMAHAQ in Healthy Individuals. (2023) (0)
- Tolerance to Allergens: How it Develops and How it Can be Induced (2014) (0)
- Subject Index Vol. 121, 2000 (2000) (0)
- Impaired nasal epithelial barrier in house dust mite sensitised allergic rhinitis patients (2014) (0)
- The Editors' Choice. (2016) (0)
- Explorer Research needs in allergy (2017) (0)
- Paper alert. Immunology. (2001) (0)
- AIT: New Insights into Mechanism (2017) (0)
- Immune‐inflammatory proteome of elite ice hockey players before and after SARS‐CoV‐2 infection (2022) (0)
- The Editors' Choice. (2017) (0)
- The Editors' Choice. (2016) (0)
- Cannabinoids induce functional Tregs by promoting tolerogenic DCs via autophagy and metabolic reprograming (2021) (0)
- Erratum to: Allergen immunotherapy for allergic asthma: protocol for a systematic review (2017) (0)
- Acknowledgements (2005) (0)
- Role of T Cells in Atopic Eczema (2006) (0)
- Issue Information (2021) (0)
- COVID-19-vaccination in patients receiving allergen immunotherapy (AIT) or biologics - EAACI recommendations (2021) (0)
- Complementary Human mDC and pDC Mechanisms Ensure Induction of Foxp3+ T Cells in Response to the Commensal Microbiota: 1258 (2011) (0)
- Suppression of Toll-like Receptors 3-, 7- and 9-induced B cell Activation and Antibody Production by Repetitive Oligonucleotides from Mammalian Telomere (2006) (0)
- Issue Information (2021) (0)
- Erratum to: Allergen immunotherapy for insect venom allergy: protocol for a systematic review (2017) (0)
- The Editors' Choice. (2019) (0)
- The Editors' Choice. (2017) (0)
- The Editors' Choice. (2016) (0)
- Low thresholds for activation and apoptosis of Th1 cells as a mechanism of Th2 predominance in atopic diseases (2005) (0)
- Obituary in memory of Giovanni Pajno. (2022) (0)
- Development and Characterization of Antisense Oligonucleotides Against Human Rhinovirus for Efficient Prevention of Asthma Exacerbation (2019) (0)
- Effect of Haemophilus influenzae, Streptococcus pneumoniae and influenza vaccinations on infections, immune response, and asthma control in preschool children with asthma. (2022) (0)
- Role of the Th2-Specific Gfi-1 Transcription Factor in Steroid Treatment of Asthma. (2009) (0)
- Antibodies Pollen Allergen , Bet v 1 , Induce Blocking Recombinant Fragments of the Major Birch T Cell Epitope-Containing Hypoallergenic (2000) (0)
- The Editors' Choice. (2017) (0)
- Legends of allergy and immunology: Kurt Blaser and major contributions to deciphering the role of T cells in allergic disease (2023) (0)
- T Cell Interaction with Epithelial Cells (2013) (0)
- The Journal of Allergy and Clinical Immunology: An update on style and substance. (2017) (0)
- Regulatory T Cells and Other Tolerogenic Mechanisms in Allergy and Asthma (2009) (0)
- LB1556 miR-10a modulates keratinocyte responses in atopic dermatitis (2018) (0)
- Animal models of allergic rhinitis (2015) (0)
- Innate lymphoid cell subsets in obese asthma patients: Difference in activated cells in peripheral blood and their relationship to disease severity (2022) (0)
- Implementation of the web‐based calculator estimating odds ratio of severe COVID‐19 for unvaccinated individuals in a country with high coronavirus‐related death toll (2022) (0)
- Reporting Standards for Diagnostic Testing: Guidance for Authors From Editors of Respiratory, Sleep, and Critical Care Journals. (2023) (0)
- Staphylococcus aureus enterotoxin B induces airway epithelial barrier dysfunction in vitro (2015) (0)
- The Editors' Choice. (2017) (0)
- “COVID-19 vaccine anaphylaxis: IgE, complement or what else?” (2020) (0)
- Development of an in vitro homeostasis model between airway epithelial cells, bacteria and bacteriophages: a time-lapsed observation of cell viability and inflammatory response. (2022) (0)
- BIOMARKERS IN THE DIAGNOSIS AND THERAPY OF ALLERGIC DISEASES AND ASTHMA (2020) (0)
- Treatment of bee venom allergic subjects with phospholipase A2 T Cell epitope peptides results in iincreased expression of mRNA encoding suppressor of cytokine signalling (SOCS) 3 and a transient increase in allergen-specific IgG/G4 (2005) (0)
- From Molecular Science to the Treatment of Allergy (1999) (0)
- The Editors' Choice. (2016) (0)
- Granzymes, IL-16, and PARP-1 increase during wildfire smoke exposure (2023) (0)
- JACI Year-in-Review Workshop (2017) (0)
- Editorial Board: Eur. J. Immunol. 10'15 (2015) (0)
- The Effect of Dexamethasone on TGF-ß-Induced Hyperplasia of Bronchial Smooth Muscle Cells (2006) (0)
- JKCF2-1 The expression and role of tight junction protein in airway smooth muscle in asthmatic subjects(Atopic eczema and related diseases,Free Paper Session 2,Japan-Korea-China Joint Symposium) (2011) (0)
- New diagnostic and research techniques in allergic rhinitis and chronic rhinosinusitis (2015) (0)
- The Editors' Choice. (2017) (0)
- Detergent-induced eosinophilic inflammation in the esophagus: A key evidence for the Epithelial Barrier Theory. (2023) (0)
- Validation of the GA(2)LEN chamber for trials in allergy Innovation of a mobile allergen exposure chamber Allergy and Asthma (0)
- The Editors' Choice. (2017) (0)
- 406 Skin barrier function genes differentially correlated to resident Staphylococci in lesional and non-lesional skin in atopic eczema (2017) (0)
- Paper alert. Immunology. (2001) (0)
- MS2-7 Claudin-1 expression in airway smooth muscle exacerbates airway remodeling in asthma (2011) (0)
- Environmental and Health Hazards by Massive Earthquakes. (2023) (0)
- The Influence Of Glucocorticoid Treatment On Trancription Factor Balance In Asthmatic Patients (2010) (0)
- The Editors' Choice. (2020) (0)
- ' s response to reviews Title : TRAIL Death Receptor-4 , Decoy Receptor-1 and Decoy Receptor-2 expression on CD 8 + T cells correlate with the disease severity in patients with rheumatoid arthritis (2010) (0)
- Regulation of Epithelial Barrier in Allergic Diseases by Cells and Cytokines (2017) (0)
- Dialysis plus ultrafiltration significantly improves the detection of cytokines in induced sputum (2013) (0)
- 479 Differential histamine H1 and H2 receptor expression determines up-regulation of Th1 and down-regulation of Th2 responses following histamine stimulation (2000) (0)
- Expression and Regulations of Tight Junctions in Airway Disorders (2014) (0)
- Spatial and single-cell transcriptomics provide insights into the complex inflammatory cell network in atopic dermatitis (2023) (0)
- Single‐cell analysis of allergic diseases (2023) (0)
- Mast Cells Suppress IL-33 Induced Innate-Type Allergic Airway Inflammation By Promoting Regulatory T Cell Expansion (2017) (0)
- S20-1 Biologicals in asthma and endotypes (2014) (0)
- EAACI Symposium: Allergen Specific Immunotherapy From Bench to Bedside (2013) (0)
- The Editors' Choice. (2016) (0)
- Referees (2002) (0)
- The Editors' Choice. (2017) (0)
- The Editors' Choice. (2018) (0)
- Reply to: “COVID‐19 pandemic and environment: Not only air pollution.” (2022) (0)
- Mechanisms of allergic diseases Mechanisms of food allergy (2017) (0)
- Proteomic and Immune Cell Alterations Upon Wildfire Smoke Exposure (2023) (0)
- Obituary: Jörg Kleine-Tebbe. (2023) (0)
- The Editors' Choice. (2016) (0)
- Detergents in Allergic Sensitization (2019) (0)
- Acknowledgements (2005) (0)
- Allergy and Inflammation (2017) (0)
- Mechanism of Tolerance to Venom Induced By Immunotherapy (2016) (0)
- 438 Differences between the microbiome of lesional and non-lesional skin in atopic dermatitis (2016) (0)
- The Editors' Choice. (2018) (0)
- Erratum to: Allergen immunotherapy for IgE-mediated food allergy: protocol for a systematic review (2017) (0)
- Induced sputum cytokines and chemokines and mechanistic pathways in adult asthma phenotypes (2013) (0)
- Allergy: New editorial team, innovative content and achievements after two years (2020) (0)
- Correction to: Highlights and recent developments in skin allergy and related diseases in EAACI journals (2018) (2020) (0)
- The Editors' Choice. (2022) (0)
- Mechanisms of allergen-specific B cell tolerance in children with cow’s milk-oral immunotherapy and natural outgrowth of milk allergy (2021) (0)
- The Editors' Choice. (2016) (0)
This paper list is powered by the following services:
Other Resources About Cezmi Akdis
What Schools Are Affiliated With Cezmi Akdis?
Cezmi Akdis is affiliated with the following schools:
